Thanks for subscribing!
- Teclistamab Plus Darzalex Found to Ease Cancer Burden in Phase 1 Trial
- Nexpovio Triple Combo Approved as Myeloma Treatment in Europe
- Tecvayli Recommended for Conditional Approval in Europe
- Pepaxti Combo Favored to Treat Advanced Multiple Myeloma in EU
- List of Rare Diseases Tops 10,000 – and Is Growing – New Analysis Finds